查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881627

細胞外基質貼片市場－全球產業規模、佔有率、趨勢、機會和預測，按應用、原料、地區和競爭格局分類，2020-2030年預測

Extracellular Matrix Patches Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Raw material, By Region, and By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球細胞外基質貼片市場規模為3,000萬美元，預計2030年將以7.9%的複合年成長率成長至4,734萬美元。細胞外基質貼片是一種生物工程材料，通常來自動物或合成材料，旨在提供結構支架，可支持細胞生長和組織再生，從而修復受損組織。全球市場擴張的主要促進因素包括慢性傷口盛行率的上升、外科手術中對先進解決方案的需求不斷成長以及再生醫學的持續進步。

市場概覽
預測期 2026-2030
2024年市場規模 3000萬美元
2030年市場規模 4734萬美元
2025-2030年複合年成長率 7.9%
成長最快的細分市場 血管修復與重建
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球細胞外基質貼片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依應用領域（心臟修復、血管修復與重建、心包膜修復、硬腦膜修復、軟組織修復、傷口癒合）
    • 依原料（牛、豬、其他）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美細胞外基質貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲細胞外基質貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區細胞外基質貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲細胞外基質貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美細胞外基質貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球細胞外基質貼片市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Cook Group Inc
  • Coloplast Corp
  • Smith & Nephew PLC
  • Koninklijke DSM NV
  • MTF Biologics
  • Boston Scientific Corp
  • Medtronic PLC
  • Baxter International Inc

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21758

The Global Extracellular Matrix Patches Market, valued at USD 30.00 Million in 2024, is projected to experience a CAGR of 7.9% to reach USD 47.34 Million by 2030. Extracellular matrix patches are bioengineered materials, often derived from animal or synthetic sources, designed to provide a structural scaffold that supports cell growth and tissue regeneration for repairing damaged tissues. The global market's expansion is primarily driven by the increasing prevalence of chronic wounds, a rising demand for advanced solutions in surgical procedures, and continuous advancements within regenerative medicine.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 30.00 Million
Market Size 2030USD 47.34 Million
CAGR 2025-20307.9%
Fastest Growing SegmentVascular repair & Reconstruction
Largest MarketNorth America

Key Market Drivers

The global extracellular matrix patches market is substantially influenced by the increasing prevalence of chronic diseases. These conditions often necessitate advanced biological solutions for effective tissue repair and regeneration. For instance, according to the World Health Organization, in May 2023, the "Chronic diseases taking 'immense and increasing toll on lives', warns WHO" report highlighted that non-communicable diseases, including those requiring tissue repair, already account for approximately three-quarters of all annual global deaths. This significant disease burden fuels an ongoing demand for innovative treatment modalities like ECM patches to manage and heal complex tissue damage.

Key Market Challenges

Stringent regulatory requirements and complex approval processes represent a substantial challenge to the growth of the Global Extracellular Matrix Patches Market. These advanced biologic therapies are subject to rigorous evaluation across diverse regions, leading to prolonged market entry timelines and significantly elevated compliance expenditures. The comprehensive nature of these regulations demands extensive clinical evidence and documentation, which diverts considerable financial and personnel resources from innovation and product development.

Key Market Trends

The integration of smart patch technology with biosensors for real-time monitoring represents a pivotal trend, enhancing extracellular matrix patches by providing continuous, actionable insights into tissue regeneration. These advanced patches utilize miniaturized sensors to track physiological parameters, enabling proactive intervention and optimized treatment through early complication detection. MedTech Europe reported over 15,900 patent applications were filed with the European Patent Office in 2023 for medical technology, a 1.3% increase from the prior year, indicating broad innovation. In May 2024, University of Chicago researchers developed "living bioelectronics," a wearable patch integrating cells with electronics for flexible skin healing, highlighting advancements for ECM patch functionality.

Key Market Players

  • Cook Group Inc
  • Coloplast Corp
  • Smith & Nephew PLC
  • Koninklijke DSM N.V.
  • MTF Biologics
  • Boston Scientific Corp
  • Medtronic PLC
  • Baxter International Inc

Report Scope:

In this report, the Global Extracellular Matrix Patches Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extracellular Matrix Patches Market, By Application:

  • Cardiac repair
  • Vascular repair & reconstruction
  • Pericardial repair
  • Dural repair
  • Soft tissue repair
  • Wound healing

Extracellular Matrix Patches Market, By Raw material:

  • Bovine
  • Porcine
  • Others

Extracellular Matrix Patches Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Extracellular Matrix Patches Market.

Available Customizations:

Global Extracellular Matrix Patches Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extracellular Matrix Patches Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Cardiac repair, Vascular repair & reconstruction, Pericardial repair, Dural repair, Soft tissue repair, Wound healing)
    • 5.2.2. By Raw material (Bovine, Porcine, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Extracellular Matrix Patches Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Raw material
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Extracellular Matrix Patches Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Raw material
    • 6.3.2. Canada Extracellular Matrix Patches Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Raw material
    • 6.3.3. Mexico Extracellular Matrix Patches Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Raw material

7. Europe Extracellular Matrix Patches Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Raw material
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Extracellular Matrix Patches Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Raw material
    • 7.3.2. France Extracellular Matrix Patches Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Raw material
    • 7.3.3. United Kingdom Extracellular Matrix Patches Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Raw material
    • 7.3.4. Italy Extracellular Matrix Patches Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Raw material
    • 7.3.5. Spain Extracellular Matrix Patches Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Raw material

8. Asia Pacific Extracellular Matrix Patches Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Raw material
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Extracellular Matrix Patches Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Raw material
    • 8.3.2. India Extracellular Matrix Patches Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Raw material
    • 8.3.3. Japan Extracellular Matrix Patches Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Raw material
    • 8.3.4. South Korea Extracellular Matrix Patches Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Raw material
    • 8.3.5. Australia Extracellular Matrix Patches Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Raw material

9. Middle East & Africa Extracellular Matrix Patches Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Raw material
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Extracellular Matrix Patches Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Raw material
    • 9.3.2. UAE Extracellular Matrix Patches Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Raw material
    • 9.3.3. South Africa Extracellular Matrix Patches Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Raw material

10. South America Extracellular Matrix Patches Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Raw material
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Extracellular Matrix Patches Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Raw material
    • 10.3.2. Colombia Extracellular Matrix Patches Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Raw material
    • 10.3.3. Argentina Extracellular Matrix Patches Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Raw material

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Extracellular Matrix Patches Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cook Group Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Coloplast Corp
  • 15.3. Smith & Nephew PLC
  • 15.4. Koninklijke DSM N.V.
  • 15.5. MTF Biologics
  • 15.6. Boston Scientific Corp
  • 15.7. Medtronic PLC
  • 15.8. Baxter International Inc

16. Strategic Recommendations

17. About Us & Disclaimer